Home / Health / Drug Recall: Pregabalin May Contain Antidepressant
Drug Recall: Pregabalin May Contain Antidepressant
17 Aug
Summary
- Teva-Pregabalin capsules recalled due to possible sertraline contamination.
- Two specific lots affected by the recall have been identified.
- Sertraline contamination could cause serious allergic reactions, including fatal ones.
Teva Canada has initiated a precautionary recall for certain Teva-Pregabalin 150 mg capsules. This action stems from routine testing that revealed a potential contamination with sertraline, a medication commonly used for depression and anxiety disorders. The recall specifically targets two lots, identified by numbers 100070495 and 100068913.
These affected capsules were distributed in Canada starting in September 2025 and are marked with an expiration date of July 31, 2027. Health Canada has issued a notice highlighting the risks, particularly for individuals with hypersensitivity or allergies to sertraline. Exposure could lead to severe side effects or a potentially fatal anaphylactic reaction. Consumers possessing products from the specified lots are strongly advised to return them to their pharmacy without delay. Pregabalin itself is prescribed for nerve damage-related pain. The presence of sertraline introduces a significant health risk for susceptible individuals, emphasizing the importance of this recall for public safety.
